Portugal’s Hovione builds spray drying capacity in US and Ireland
The Portuguese contract development and manufacturing organization (CDMO) Hovione continues its spray drying expansion with investments in its sites in Ireland and New Jersey, US.
Globalization
Adragos Pharma snaps up Baccinex to expand CDMO network
The Swiss aseptic fill-finish manufacturing specialist Baccinex has become the latest in a string of acquisitions by the German contract development and manufacturing organization Adragos Pharma.
How CDMOs can optimize operations and balance costs ahead of the 2032 BioSecure Act
As the BioSecure Act approaches its 2032 implementation, Contract Development and Manufacturing Organizations (CDMOs) must prepare for significant industry shifts.
FDA approves Rusan Pharma’s manufacturing facility in India, paving the way for expanded US presence
Rusan Pharma Private Limited has announced that its active pharmaceutical ingredient (API) manufacturing facility in Ankleshwar, Gujarat, has been granted Good Manufacturing Practice (GMP) approval by the FDA.
Phathom Pharmaceuticals receives FDA approval for Voquezna to treat non-erosive GERD
Phathom Pharmaceuticals, Inc.dedicated to developing and commercializing treatments for gastrointestinal (GI) diseases, announced today that the US Food and Drug Administration (FDA) has approved Voquezna (vonoprazan) 10mg tablets for the relief of...
Avista and Hamilton Lane join forces to Propel growth and innovation at Cosette Pharmaceuticals
Avista, a New York-based private equity firm focused on healthcare, and Hamilton Lane, a global private markets investment management firm, have announced that funds managed by Hamilton Lane have acquired a significant equity interest in Cosette...
Nipro's $397.8M investment brings 232 new jobs to Greenville, NC with exciting new facility
Japanese medical devices company, Nipro Medical Corporation, a giant in the healthcare and medical device industry, has announced a major investment of $397.8 million to establish its first North American manufacturing center of excellence in Greenville,...
DIA 2024
Discover how Marwan Fathallah is transforming DIA and hoping to revolutionize global healthcare
At the DIA 60th annual conference in San Diego, senior editor Liza Laws from Outsourcing Pharma had the opportunity to sit down with Marwan Fathallah, President and CEO of DIA.
Esteve Pharmaceuticals expanding Girona plant to enhance the production of APIs
Esteve Pharmaceuticals has announced a substantial investment of €100 million ($108 million) to build a new manufacturing unit at its Girona plant.
Vector Labs' Pam James - from failed 'experiments' with dad to a doctorate in immunology
Her grandmother was in a marching band in the early 1900s and mom was only one of two in her graduating class as a pharmacist and her dad, an inventor with more than 30 patents.
Keensight Capital supports CatSci for ownership of specialist chromatography provider Reach Separations
CatSci, a UK-based innovation partner for the development of pharmaceutical manufacturing processes, will be expanding its service offering with the acquisition of Reach Separations.
ELRIG UK and The Protein Society partner to advance protein sciences in drug discovery
ELRIG UK, a leading organization in the drug discovery community, has partnered with The Protein Society (TPS) to host a groundbreaking conference on ‘Protein Sciences in Drug Discovery’.
Inside the FDA's Accelerated Approval: How it’s extending lives and improving patient care
Last week, OSP had the pleasure of speaking with Ginny Beakes-Read at the DIA Global conference.
How is uMotif empowering clinical trials with advanced eCOA technology?
Clinical trials play a crucial role in driving medical progress, and the accurate capture of patient data is fundamental to their success.
Roquette's US innovation center marks first year of pharmaceutical advancements
As Roquette's US Innovation Center marks its first anniversary, Roquette took the opportunity to reflect on its interesting journey and achievements over the past year.
UK-based company selling breakthrough cannabis-based medicines now supplying the US
UK based Celadon Pharmaceuticals Plc, that specializes in the development, production, and sale of breakthrough cannabis-based medicines, announced that it has begun shipping to the US.
Swixx BioPharma expands to Latin America through strategic acquisition of Biopas
Swixx BioPharma AG, a platform dedicated to unlocking access to e medicines, has announced its strategic expansion into Latin America.
How one company is incorporating patient perspectives in clinical trials
With Clinical Trials Day earlier in the week (May 20) OSP spoke to patient-focused companies to see what was happening in the clinical trials arena.
Inato study digs deep into the global clinical trial marketplace, but what were the main findings?
Inato, the global clinical trial marketplace, recently announced the results from a survey of clinical research sponsors and sites to find out what the frustrations were, why the disappointing outcomes were so frequent - and crucially what the sponsors...
Unlocking Synergies: LGM Pharma's strategic approach to sourcing and growth in India
In an extensive and enlightening chat with Prasad Raje, the CEO of LGM Pharma, OSP gained profound insights into the company's trajectory within the pharmaceutical industry.
Made in the USA: Ultrahuman to become first facility dedicated to producing wearable rings
Ultrahuman, a force in wearable technology, has boldly planted its flag on American soil with the inauguration of UltraFactory.
Bios Health Group launches innovation circle to advance life sciences
Bios Health Group, a leading strategic and investment partner for life science companies and investors, has officially introduced the Bios Innovation Circle.
Qinecsa Solutions acquires Insife to strengthen pharmacovigilance technology
Qinecsa Solutions (Qinecsa), a lead company in technology-driven end-to-end pharmacovigilance solutions has announced its acquisition of Insife ApS (Insife), a Danish-based firm specializing in innovative pharmacovigilance platforms.
Merck announces €300 million investment in new life science facility in Korea
Merck set to invest over €300 million in new production center in South Korea.
Roquette snaps up IFF Pharma Solutions for $2.85 billion
Roquette has acquired the pharma solutions division at International Flavors & Fragrances, in a deal up to $2.85 billion.
Lonza to acquire manufacturing site from Roche in major $1.2 billion deal
Lonza is set to acquire a large-scale manufacturing site from Roche-owned U.S. giant Genentech for $1.2 billion.
DCAT 2024
What are the global pharma giants' goals at DCAT 2024? A written roundtable reveals all
The curtains have risen on DCAT 2024 in the vibrant heart of New York City, and leading pharmaceutical companies from around the world have converged for a week of innovation, collaboration, and strategic dialogue.
Drug discovery and global player, Cresset, moves team into Boston marking major turning point
Greater integration is to take place between the US and UK following an expansion says Cresset, a provider of integrated in-silico solutions for drug discovery.
AION Labs launches combinAble.AI to revolutionize antibody design with AI
In a bid to reshape the landscape of targeted antibody design, AION a creative venture studio based in Israel has introduced CombinAble.AI.
Two new purpose-built facilities built for Almac Group in Northern Ireland to meet growing demand
Almac Group, a global leader in CDMOs, announced today (March 6) that it has unveiled two new purpose-built facilities at its headquarters in Northern Ireland.
ICON's Kathleen Mandziuk's journey from nursing to respected drug development innovator
Mandziuk is vice president, project management, eClinical Development & Delivery, at ICON and she says nothing could have prepared the health industry for the global impact the Covid pandemic has had.
Initiative by Innovative Trials to boost patient retention inspired by boy's love of collecting
The father of a boy diagnosed with acute lymphoblastic leukemia at the age of nine, inspired by his son's love of collecting, has created patches of positivity for children going through cancer treatment to collect.
At risk patients with rare diseases need a higher level of support - and the process must change
February will see the 16th annual Rare Disease Day which raises awareness of the more than 7,000 identified rare diseases worldwide.
Saama's agreement with Pfizer to fundamentally change drug development processes, helping more people worldwide
Today (February 12) Saama has announced a newly expanded, multi-year agreement with biopharma giant, Pfizer, to help expedite clinical research.
Charac's funding from Traditum to help pharmacies digitalize in preparation for government's new edict
With independent pharmacies now facing significant challenges, healthcare SaaS provider Charac was pleased to announce more investment so it can accelerate a digitization drive.
From a fascination with viruses to a desire to make a lasting impact, Immunic's Hella Kohlhof shares her journey
Wedneday is Women in Science day and we have a fantastic interview with Hella who is co-founder and chief scientific officer of Immunic Therapeutics.
Top minds from pharma, academia and tech to sit on ArisGlobal's new generative AI council
Life sciences technology company ArisGlobal, has announced the formal charter for the new generative AI Council, which will sit for the first time this month in a bid to advance life sciences innovation.
IQVIA: Healthcare data regional compliance complexity requires AI, ML and NLP automation
Always the buzz theme at pharma conferences, the subject of artificial intelligence (AI) continues to crop up more and more frequently. Naturally with more and more people using it for work, new regulations on data use and management are starting to appear.
Bora Pharmaceuticals expands into the US for the first time with Upsher-Smith acquisition
Bora Pharmaceuticals is set to acquire US pharma manufacturer Upsher-Smith Laboratories for up to $210 million, it says, to fuel global expansion.
GSK to pump £200 million into UK to boost medicine production and buys Aiolos Bio for $1.1 billion
Pharma giant, GSK, plans to invest £200 million ($253 million) into the UK over the next two years and has acquired Aiolos Bio for $1.1 billion (£870 million).
Partnership puts Israel on the AI and computational science map
AION Labs, the first-of-its-kind venture studio today (January 8) announced its new partnership with Amiti Ventures, a leading early-stage venture capital firm in Israel.
ACG's capsule manufacturing facility secures place in WEF's Global Lighthouse community
Integrated supplier and service provider to the pharma industry, ACG, has secured a position in the World Economic Forum's prestigious community of Global Lighthouses.
Five decentralized clinical trial organizations raising big VC cash
Decentralized clinical trials (DCTs) are gaining increasing interest as they have the potential to make clinical trial operations quicker, more efficient and more accessible to patients. Check out five DCT organizations that have raised big venture...
The key pharmaceutical trends from 2023 according to industry leaders
The pharmaceutical industry in 2023 has seen many investments, partnerships, acquisitions and more. As the year ends, industry leaders give the biggest trends to look for in 2024, with artificial intelligence being a hot topic.
Merck signs $70 million deal to commercialize Abbisko’s new cancer drug in China
Merck has entered into a $70 million licensing agreement with Abbisko Therapeutics for pimicotinib, which is currently being evaluated in a phase 3 study for the treatment of tenosynovial giant cell tumor (TGCT).
Abingworth raises $356 million for late-stage pharma and biotech clinical programs
Life sciences investment group and part of global investment firm Carlyle, Abingworth announced last week it had exceeded its $300 million target by $56 million.
Cresset targets international growth with Innovate UK Scaleup Program
Provider of solutions for computer-aided drug design (CADD), Cresset, says it has ambitions plans to scale up international operations.
AstraZeneca’s lead lung cancer drug,Tagrisso, to surpass $7BN in sales
Small molecule drugs are carving a significant niche in lung cancer treatment, according to data and analytics company, GlobalData, and Tagrisso is well on its way to dominating the market.
Astellas to pump $352 million into manufacturing facility in Ireland
The Japanese firm Astellas Pharma will apply for planning permission to construct a drug manufacturing facility in Tralee, Co. Kerry, Ireland worth around €330 million ($352 million).
Emerald Cloud Lab makes Symbolic Lab Language open source for research
Emerald Cloud Lab (ECL) was the world’s first highly automated cloud laboratory, was set up by two friends, Brian Frezza and D.J Kleinbaum who grew up together and joined forces after their PhDs to found the company.